Net Loss of Vista Pharmaceuticals reported to Rs 0.86 crore in the quarter ended June 2024 as against net loss of Rs 0.95 crore during the previous quarter ended June 2023. Sales declined 9.09% to Rs 1.80 crore in the quarter ended June 2024 as against Rs 1.98 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales1.801.98 -9 OPM %-43.33-45.96 - PBDT-0.99-1.11 11 PBT-1.17-1.28 9 NP-0.86-0.95 9 Powered by Capital Market - Live News

Vista Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 August 2024.Powered by Capital Market - Live News

Net profit of Vista Pharmaceuticals reported to Rs 0.09 crore in the quarter ended March 2024 as against net loss of Rs 0.30 crore during the previous quarter ended March 2023. Sales reported to Rs 3.13 crore in the quarter ended March 2024. There were no Sales reported during the previous quarter ended March 2023.For the full year,net loss reported to Rs 4.51 crore in the year ended March 2024 as against net loss of Rs 5.66 crore during the previous year ended March 2023. Sales rose 929.00% to Rs 10.29 crore in the year ended March 2024 as against Rs 1.00 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales3.130 0 10.291.00 929 OPM %8.310 --34.69-444.00 - PBDT0.08-0.47 LP -4.46-5.25 15 PBT-0.10-0.62 84 -5.18-5.87 12 NP0.09-0.30 LP -4.51-5.66 20 Powered by Capital Market - Live News

Vista Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 May 2024Powered by Capital Market - Live News

Vista Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 6 March 2024 .Powered by Capital Market - Live News